Skip to content

Study on correlation between circadian rhythm and microflora

Study on correlation between circadian rhythm and microflora

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078031
Enrollment
Unknown
Registered
2023-11-27
Start date
2023-11-27
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysfunction of circadian rhythm

Interventions

Normal diet group:Circadian rhythm disorders, Normal diet
Meal replacement intervention group:Circadian rhythm disorders, Meal replacement intervention
Control group:None

Sponsors

He'nan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The subjects are healthy people; (2) Age between 18 and 80 years (age calculated as the difference between the date of screening survey and the date of birth); (3) Currently not participating in other research projects; (4) Signing informed consent; (5) Mental health and self-care; (6) Good compliance

Exclusion criteria

Exclusion criteria: (1) pregnant and lactating women; (2) It cannot guarantee sufficient time to participate in the project; (3) suffering from serious mental illness; (4) suffering from serious organic diseases such as cancer, coronary heart disease, myocardial infarction and stroke; (5) suffering from infectious diseases such as tuberculosis and AIDS; (6) Physical disability, or other reasons caused by the inability to take care of themselves; (7) Subjects with acute or chronic inflammatory diseases or infectious diseases, or who are receiving antibiotics, probiotics, probiotics, or any other medication that may affect the intestinal microbiome during the first 3 months of enrollment; (8) Use of antibiotics in the past 3 months for 3 days or more; (9) Patients with moderate or severe renal impairment (serum creatinine > 2mg/dL or 177mmol/L), or abnormal liver function (ALT>2 times the upper limit of normal); Moderate to severe chronic obstructive pulmonary disease; Patients with severe hypertension and cerebrovascular accidents; (10) complicated with severe cardiovascular, cerebrovascular, liver, kidney and hematopoietic diseases; (11) binge drinking (drinking more than 5 times a week, with an average of more than 2 liangjiu or half jin of yellow rice wine or 5 bottles of beer each time); (12) Patients who have received medication in the past 3 months for the following diseases: cholecystitis, digestive tract ulcers, urinary tract infections, acute pyelonephritis, cystitis, hyperthyroidism and other thyroid dysfunction; (13) Anemia: hemoglobin <10g/dl.

Design outcomes

Primary

MeasureTime frame
Islet function;

Secondary

MeasureTime frame
Intestinal microbial composition and functional characteristics;Cognitive function;Anxiety and depression;hormone;Composition and functional characteristics of oral microorganisms;Composition and functional characteristics of skin microorganisms;Body fat;Immunity;Cerebrovascular function monitoring;

Countries

China

Contacts

Public ContactHuijuan Yuan

He'nan Provincial People's Hospital

lmls3712@163.com+86 135 1389 1997

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026